Entity Details

Primary name COG5_HUMAN
Entity type UniProt
Source Source Link

Details

AccessionQ9UP83
EntryNameCOG5_HUMAN
FullNameConserved oligomeric Golgi complex subunit 5
TaxID9606
Evidenceevidence at protein level
Length839
SequenceStatuscomplete
DateCreated2002-08-30
DateModified2021-06-02

Ontological Relatives

GenesCOG5

GO terms

Show/Hide Table
GOName
GO:0000139 Golgi membrane
GO:0005654 nucleoplasm
GO:0005794 Golgi apparatus
GO:0005829 cytosol
GO:0006888 endoplasmic reticulum to Golgi vesicle-mediated transport
GO:0006891 intra-Golgi vesicle-mediated transport
GO:0015031 protein transport
GO:0016020 membrane
GO:0017119 Golgi transport complex
GO:0032588 trans-Golgi network membrane
GO:0048219 inter-Golgi cisterna vesicle-mediated transport

Subcellular Location

Show/Hide Table
Subcellular Location
Cytoplasm
Golgi apparatus membrane

Domains

Show/Hide Table
DomainNameCategoryType
IPR019465 Conserved oligomeric Golgi complex subunit 5FamilyFamily

Diseases

Show/Hide Table
Disease IDSourceNameDescription
613612 OMIMCongenital disorder of glycosylation 2I (CDG2I)A multisystem disorder caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions. Congenital disorder of glycosylation type 2I is characterized by mild neurological impairments. The disease is caused by variants affecting the gene represented in this entry.